Concepedia

Gordon J. Freeman

GJ

Statistics

Publications

4

Citations

8.9K

H-Index

4

Active since

1995

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Kyoto University

Gordon J. Freeman is an author at Dana-Farber Cancer Institute specializing in immunology, life sciences, and t cell activation.

Publications per year

1995–2001

4

Publications

4

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

Gordon J. Freeman, Andrew J. Long, Yoshiko Iwai et al. · The Journal of Experimental Medicine · 2000 · 5.2K citations · Full text

, , +17

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

Yvette Latchman, Clive R. Wood, Tatyana Chernova et al. · Nature Immunology · 2001 · 2.9K citations

, , +14

ICOS is critical for CD40-mediated antibody class switching

Alexander J. McAdam, Rebecca J. Greenwald, Michele A. Levin et al. · Nature · 2001 · 644 citations

, , +8

Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion

Yuji Ueda, Bruce L. Levine, Mark Huang et al. · International Immunology · 1995 · 74 citations

, , +12

1–4 of 4